Mucosal ACP vaccine formulated with the STING agonist diABZI drives protective Th1/Th17 responses and serum bactericidal antibodies against Neisseria gonorrhoeae (140609)
Aleksandra E Sikora
1
2
,
Abhishek Chanda
1
,
Ines Cadena
1
,
Junaid Nazir
1
,
Laura Springgay
2
,
Ian P Rose
2
,
Jinu Abraham
2
,
chenwei Lin
3
,
Mansab Saleemi
1
,
Andrew Macintyre
4
,
Victor DeFilippis
2
- Oregon State University, Corvallis, OR, United States
- Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, Oregon, United States
- Proteomics Shared Resource, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States
- Duke Human Vaccine Institute and Department of Medicine, Duke University School of Medicine, Durham, North Carolina, United States